bpc-157 purchase legal status Status: FDA Regulations and Compounding Understanding the Legal Risks of
Description
If there is no signal at four weeks in a compliant patient, the probability of benefit with continued use is low
Immune layer: Thymosin alpha-1 for those with documented Th2-dominant immune profiles seeking to restore balance
vials must be discarded after opening, regardless of remaining volume
Most patients go through 23 vials per month
